Glipizide Tablet, Extended Release
Product Images NDC 50090-6849

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 50090-6849). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Glipezide Usp (C65265e1 A7eb 43ea 890a 00a227570956 01)

Glipezide Usp (C65265e1 A7eb 43ea 890a 00a227570956 01)
Chemical structure diagram of Glipizide, illustrating its molecular framework including a pyridine ring, sulfonylurea moiety, and cyclohexyl group as part of the compound structure.*
FDA Label Image

Label Image (Lbl500906849)

Label Image (Lbl500906849)
Glipizide 10 mg extended-release tablets label from A-S Medication Solutions. The label indicates oral administration, 90 tablets per bottle, storage instructions between 68 to 77 degrees F away from moisture and humidity, and includes a lot number and NDC 50090-6849-0. It also notes the tablets are film-coated and contain 18 mg of Glipizide extended-release.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.